BioInvent Announces Publication of Data in Leading Cancer Journal Immunity
Go back to BioInvent Announces Publication of Data in Leading Cancer Journal Immunity| (NYSE: BINV) | Delayed: 43.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.17 | 52 Week High | $ | |||
| Open | $43.17 | 52 Week Low | $ | |||
| Day High | $43.17 | P/E | N/A | |||
| Day Low | $43.17 | EPS | $ | |||
| Volume | 1,052 | |||||

